Facet Biotech Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Redwood City CA United States (2008)
Status: Acquired by Abbott (2010)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Colitis (Phase 3)

Colitis, Ulcerative (Phase 3)

Crohn Disease (Phase 2)

Cytomegalovirus Retinitis (Phase 2)

Diabetes Mellitus (Phase 2)

Digestive System Diseases (Phase 2)

Fistula (Phase 2)

Gastrointestinal Diseases (Phase 2)

Graft vs Host Disease (Phase 2)

Heart Failure (Phase 1)

Hypertension (Phase 2)

Inflammatory Bowel Diseases (Phase 2)

Intestinal Diseases (Phase 2)

Leukemia (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Multiple Myeloma (Phase 1)

Neoplasms, Plasma Cell (Phase 1)

Ovarian Neoplasms (Phase 2)

Peritoneal Neoplasms (Phase 2)

Psoriasis (Phase 2)

Retinitis (Phase 2)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 29
  • # of Trial APIs: 25